January 1996 through March 1998
Below are presented in vitro sensitivity data on bovine isolates obtained from cases of BRD at the University of Nebraska Veterinary Diagnostic Laboratory, Lincoln, from January 1996 through March 10, 1998.
Florfenicol continues to demonstrate outstanding activity against the three major bacteria associated with BRD. There is evidence of increasing resistance to other antibiotics commonly employed in the treatment of this disease.
Mannheimia (Pasteurella) haemolytica
| 1996 | 1997 | 1998 | |
| Florfenicol | 29/100 | 78/100 | 64/100 |
| Spectinomycin | 32/62.5 | 77/57.1 | 65/60 |
| Tetracycline | 32/78.1 | 78/66.8 | 65/56.9 |
| Tilmicosin | 32/87.5 | 77/76.6 | 64/68.7 |
Pasteurella multocida
| 1996 | 1997 | 1998 | |
| Florfenicol | 10/100 | 43/100 | 38/100 |
| Spectinomycin | 13/100 | 45/64.4 | 41/82.9 |
| Tetracycline | 13/100 | 45/80 | 41/73.2 |
| Tilmicosin | 13/92.3 | 45/88.9 | 41/92.2 |
Haemophilus somnus
| 1996 | 1997 | 1998 | |
| Florfenicol | 12/100 | 29/100 | 17/100 |
| Spectinomycin | 13/84.6 | 29/72.4 | 17/76.5 |
| Tetracycline | 13/92.3 | 29/86.2 | 17/88.2 |
| Tilmicosin | 13/69.2 | 28/57.1 | 16/62.5 |